Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2002
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244654A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244636A1 Benzimidazoles, production thereof and the use thereof as antithrombotic
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244452A1 Urotensin-ii receptor antagonists
10/02/2002EP0841946B1 Methods for treatment of allergic asthma
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002DE10114762A1 Treatment of lung diseases, especially adult respiratory distress syndrome, by administration of cysteine protease inhibitor, especially calpain inhibitor
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002DE10108122A1 Arzneimittel auf Basis von Tramadol Medicines based on tramadol
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1371721A Medicine for preventing and curing sore-throat
10/02/2002CN1371719A Smellting treated Chinese medicine
10/02/2002CN1371706A Aloes lozenge and preparation method thereof
10/02/2002CN1371703A Ampelopsis grossedentata lozenge
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458946 Crystals of diuridine tetraphosphate or salt thereof, process for producing the crystals, and process for producing the compounds
10/01/2002US6458846 Ion channel modulating agents
10/01/2002US6458844 Antiinflammatory agents
10/01/2002US6458837 Lipophilic diesters of chelating agents
10/01/2002US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002US6458364 Non-splicing variants of gp350/220
10/01/2002US6458361 Soaking in water, heating beyond boiling point, stirring, filtering
10/01/2002US6458338 Amino acid stabilized medicinal aerosol formulations
10/01/2002CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2123909C New combination of formoterol and budesonide
09/2002
09/26/2002WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074806A2 New interferon beta-like molecules
09/26/2002WO2002074780A1 Chemical compounds
09/26/2002WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074763A1 Benzimidazol derivatives modulate chemokine receptors
09/26/2002WO2002074761A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074733A2 Tryptase-inhibitors
09/26/2002WO2002074732A2 Tryptase-inhibitors
09/26/2002WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6?
09/26/2002WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors
09/26/2002WO2002074328A1 Methods of treating respiratory conditions
09/26/2002WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074309A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
09/26/2002WO2002074301A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
09/26/2002WO2002074292A2 Hormone replacement therapy
09/26/2002WO2002074249A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/26/2002WO2002074034A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists
09/26/2002WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus
09/26/2002WO2002032461A3 Protein c or activated protein c-like molecules
09/26/2002WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002WO2002026996A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
09/26/2002WO2002026954A3 Truncated phosphodiesterase-7 polypeptides
09/26/2002WO2002004439A3 Thiophene retinoids
09/26/2002WO2002000710A3 B7-like molecules and uses thereof
09/26/2002WO2001098332A3 Secreted redox proteins
09/26/2002WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
09/26/2002WO2001083775A3 Proteases
09/26/2002WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
09/26/2002WO2001032156A3 Methods for treating fibroproliferative diseases
09/26/2002US20020138860 Novel uses of mammalian CCR6 receptors and related reagents
09/26/2002US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
09/26/2002US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma
09/26/2002US20020137892 An isolated peptide transmitter-like receptor polypeptide with specific amino acid sequence or variant which has immunomodulatory, neuromodulatory and endocrinomodulatory activity
09/26/2002US20020137792 Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
1 ... 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 ... 878